Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05751434 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

StatusRecruiting
PhasePhase 2
Started2023-02-10
View on ClinicalTrials.gov ↗

Amendment history

2026-07-29
Study Status, Study Design, Contacts/Locations v19
Enrollment reopened
Enrollment increased: 36 → 102 participants
Study sitesdetails revised at 10 of 10 sites
2026-06-02
Study Status, Contacts/Locations v18
Primary completion pushed: 2027-02-10 → 2028-03-01
Completion pushed: 2027-02-10 → 2028-06-01
Study sitesdetails revised at 1 of 10 sites
2026-05-15
Study Identification, Study Status, Sponsor/Collaborators, Oversight, Study Description, Conditions, Contacts/Locations v17
Sponsor changed: Memorial Sloan Kettering Cancer Center → City of Hope Medical Center-11 characters
WasMemorial Sloan Kettering Cancer Center
NowCity of Hope Medical Center
Study sites9→10
Study description+758 characters
The purpose of this study is to find out the effects of exercise therapy on indicators of prostate cancer in people with low-risk prostate cancer who are on active surveillance. The exercise therapy in this study will be regular home-based walking sessions on a treadmill, and that therapy will be as [...]
2026-05-08
2 amendments v15-v16
2 re-verifications since 2026-02-04, no change to tracked fields
2025-11-26
Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations v14
Trial statusRecruiting→Active, Not Recruiting
Enrollment targetestimated 102→confirmed 36
Study sitesdetails revised at 9 of 9 sites
Show 13 earlier versions
2025-09-05
Study Status v13
Re-verified, no change to tracked fields
2025-07-11
Study Status, Contacts/Locations v12
Study sitescontacts updated at 7 of 9 sites
2025-04-17
3 amendments v9-v11
3 re-verifications since 2025-02-17, no change to tracked fields
2024-12-19
Study Status, Contacts/Locations v8
Study sitesdetails revised at 1 of 9 sites
2024-12-12
Study Status, Eligibility v7
Eligibility criteria+128 characters
[...] earance by an MSK Exercise Physiologist (i.e., review of ECG and PAR-Q) BMI <40 kg/m^2 Cleared for exercise participation as per pre-screening clearance via the Physical Activity Readiness Questionnaire (PAR-Q+) (Appendix B) Exclusion Criteria: Enrollment in any other program that may [...]
2024-11-06
Study Status, Contacts/Locations v6
Study sites8→9
2024-01-09
Study Status v5
Re-verified, no change to tracked fields
2023-07-26
Study Status, Eligibility v4
Eligibility criteria+41 characters
[...] djuvant anticancer treatment of any kind for prostate cancer in the last 5 years Any history of systemic anticancer therapy in the last 15 years Distant metastatic malignancy of any kind Any other conditi [...]
2023-07-11
2 amendments v2-v3
2 re-verifications since 2023-04-24, no change to tracked fields
2023-03-15
Study Status, Outcome Measures, Contacts/Locations v1
Primary endpoints2 to 1 entries
Change in Nimbosusmolecular, radiologic, and pathologic nimbosus hallmarks evaluation from baseline to 12 months Change in Nimbosus hallmarks evaluation from baseline to 6 monthsfollow-up
Study sites8 entries, revised
University of California, Los Angeles (Data and Specimen Analysis Only)
2023-02-20
Original filing
To determine the effects of exercise therapy on molecular, radiologic, and pathologic nimbosus hallmarks versus usual care control in men on Active Surveillance for localized prostate cancer.
Trial Details
NCT Number NCT05751434
Lead Sponsor City of Hope Medical Center
Conditions Prostate Cancer, Prostate Adenocarcinoma, Localized Prostate Carcinoma
Enrollment 102 participants
Start Date 2023-02-10
Primary Completion 2028-03-01 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-30